Bristol Myers Squibb CEO Chris Boerner described Cobenfy, a new drug to treat schizophrenia and may also help with bipolar disorder and Alzheimer's disease.
Catatonic schizophrenia is one feature of a serious mental illness called schizophrenia. Schizophrenia prevents you from separating what’s real from what’s not, a state of mind called ...
Disclosure: No competing financial interests declared. The prevalence of paranoid symptoms in older adults is high. Collateral information is crucial for accurate identification and diagnosis of ...
You may have heard that frequent snoring is a sign of sleep apnea. It's true that snoring is one of the most common symptoms. But not everyone who has sleep apnea snores. And of course ...
Treatment-resistant schizophrenia (TRS) is generally understood as a failure to respond to at least two trials of antipsychotic medication administered at an adequate dose and duration (Polese et al., ...
The researchers highlighted that a simple visual test could be developed to help identify which individuals may benefit from worry interventions for paranoia. Lead author, Santiago Castiello, of Yale ...